Ignite Creation Date:
2025-12-26 @ 11:13 AM
Ignite Modification Date:
2026-05-02 @ 12:28 AM
Study NCT ID:
NCT04854928
Status:
UNKNOWN
Last Update Posted:
2021-09-20
First Post:
2021-04-21
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study to Evaluate a Single Dose of LTX-109 in Subjects With COVID-19 (Coronavirus Disease 2019) Infection.
Sponsor:
Pharma Holdings AS
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
C21-109-09
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |